Reply to "A better interpretation of data regarding the opioid switching to methadone".
BMC Palliat Care
; 22(1): 66, 2023 Jun 07.
Article
in En
| MEDLINE
| ID: mdl-37280625
In our article ?Methadone switching for refractory cancer pain' (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid switching to methadone in the Matters Arising. In this article, we answered the questions in Mercadante et al.'s comments one by one.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pain, Intractable
/
Cancer Pain
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
BMC Palliat Care
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom